The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
about
The Janus kinases (Jaks)SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptorPrinciples of interleukin (IL)-6-type cytokine signalling and its regulationPolymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosusBasal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motifHemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1Ubiquitination-mediated regulation of interferon responsesHuman TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndromeRegulation of interleukin-10 receptor ubiquitination and stability by beta-TrCP-containing ubiquitin E3 ligaseA novel requirement for Janus kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cellsTYK2 kinase activity is required for functional type I interferon responses in vivoJak2 is a negative regulator of ubiquitin-dependent endocytosis of the growth hormone receptorKinase Inactive Tyrosine Kinase (Tyk2) Supports Differentiation of Brown Fat Cells.Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitisHuman metapneumovirus inhibits IFN-β signaling by downregulating Jak1 and Tyk2 cellular levels.Structural basis of recognition of interferon-α receptor by tyrosine kinase 2Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited.Interferon-stimulated genes: a complex web of host defenses.The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-beta production.Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.West Nile virus infection induces depletion of IFNAR1 protein levelsSuppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor.Three lysine residues in the common β chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signalingImpairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytesA new modality for immunosuppression: targeting the JAK/STAT pathway.In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activityUbiquitin chains in the ladder of MAPK signaling.Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosisProtein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapiesGenetics of SLE: functional relevance for monocytes/macrophages in diseaseLigand-independent pathway that controls stability of interferon alpha receptorThe role of Janus kinases in haemopoiesis and haematological malignancy.Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasomeSeparate endocytic pathways regulate IL-5 receptor internalization and signalingHematopoietic cytokine receptor signaling.Dietary apigenin potentiates the inhibitory effect of interferon-α on cancer cell viability through inhibition of 26S proteasome-mediated interferon receptor degradationRegulation of prolactin receptor levels and activity in breast cancerBiology and significance of the JAK/STAT signalling pathways.
P2860
Q21194856-B2F6C7C3-50B5-41ED-B10E-B7700469F4A0Q24297139-7BD09AA8-A022-4874-AE6D-82BFC1E742E3Q24530173-BF105664-8773-44F7-9A9E-5BAEDCD9760FQ24530690-95E3A859-E24D-49B8-B378-894F03C53750Q24649769-18B043A0-CA4A-4722-88D6-1EAFD17F494CQ26700091-1645483A-F4D9-43BB-9AF6-BC88450039D1Q26853323-DFD0E591-0CF9-4661-9239-7C616D9380BEQ28266613-DD758414-A7E2-4605-913E-E67240385B66Q28477869-97AC7719-B05C-469D-9CB4-90E0FCF7389EQ28478203-0642B723-4F7F-4C98-A531-71FA435CBB2EQ28728338-04B40707-908E-4678-83B6-0E0F59A6DED3Q28742942-9BB07711-6C2D-4E67-9C2A-2B8C9AA6EFCDQ30275543-31A1914F-BC78-41C7-A47E-F13E6BE284F1Q33834191-A3035D64-1E2C-4AB8-B33F-9224EAC0F09FQ34031372-20557C94-2FCF-495D-AC13-D05888037E9AQ34165581-062FCC70-E07E-43AF-B100-0189B1DC0680Q34181570-4714C6F2-F8FE-4102-8698-33678788E72BQ34405609-724E4ED8-1427-44F1-9595-AE14FE5BA92DQ34479188-4B70EF5D-DE83-4F72-90D2-E99BAA3FDC38Q34718163-040E7783-3D6E-4939-B12B-F487DB3997C0Q35159163-73A0F6BD-32F5-47B7-950B-DA458FCAF605Q35311132-D54D0E25-B3AE-4DD0-9B0A-E838114FC59EQ35372365-9623F4F1-5C69-4656-94A0-5F111E2F43F5Q35562844-F51B4CCE-D835-403D-B79B-C50679F02099Q35590991-15E8D110-DCC9-4443-A2CA-7DB26BC0D53AQ35825869-3F830EEE-8BB2-4441-BB91-B9BB26533CE5Q36107965-056850C6-DF4B-4DD8-8F54-19642705C1C6Q36108376-30CA0E80-0946-465C-9ADB-9F2FB158DE2EQ36176561-6260ABD2-2884-4CE9-AAC8-268444054561Q36437015-1E145665-C4D0-48E6-8729-74E07E551485Q36438876-DBD21FD4-49A7-4C83-A749-31EB668C1835Q36477315-48619946-685B-4C8A-B161-5FB6356E0138Q36527760-2C3097A7-CE21-4EDC-BE17-333C2AAB1A34Q36623471-86D6A631-8778-4F10-9742-F99C3F3EB5F9Q36782542-C59C65C9-52F2-46D6-8F38-B349BEF21E8BQ36803842-08D16C74-079B-494C-BCB8-2C1986197326Q36970188-6286B314-E0B8-4B2E-AB37-E52D363B04BBQ37054312-1A68FD20-816C-4CBB-996B-8236B4C0455DQ37060370-0F532F1B-0F56-47E7-800B-9C6576BC9412Q37146441-FD4F4037-14F8-4783-9FD5-C0CA6EF8E981
P2860
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@ast
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@en
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@nl
type
label
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@ast
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@en
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@nl
prefLabel
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@ast
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@en
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
@nl
P2093
P2860
P50
P356
P1433
P1476
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression
@en
P2093
Elisabetta Dondi
Josiane Ragimbeau
Pierre Eid
P2860
P304
P356
10.1093/EMBOJ/CDG038
P407
P577
2003-02-01T00:00:00Z